摘要:
A method of diagnosing and prognosticating an acquired central nervous system injury (ACNSI) in a subject that includes: (a) obtaining a test sample from the subject (b) comparing levels a biomarker in the test sample with known normal or abnormal reference levels of the biomarker. A change (increase or decrease) in the levels of the biomarker in the test sample relative to the known reference levels of the biomarker is indicative of ACNSI diagnosis in the subject, the biomarker being one or a combination of two or more of the proteins listed in Table 2. ACNSI includes concussion and primary blast in blast-induced traumatic brain injury.
摘要:
A method of diagnosing acquired CNS injury (ACNSI) in a subject comprising: (a) obtaining a test sample from the subject (b) comparing levels of a lipid species or a cohort of multiple lipid species in the test sample with the levels of the single lipid species or the cohort of multiple lipid species in a control sample, or comparing to a normal reference range, (i.e. non- ACNSI (referred to as "normal") subjects) using quantitative measurements, wherein a change (i.e. a drop or an increase) in the level of the lipid species or the cohort of multiple lipid species in the test sample relative to the control sample is indicative of ACNSI in the subject.
摘要:
A method of diagnosing central nervous system injuries such as acquired brain injury (ABI) and/or acquired spinal cord injury (ASI), including mild TBI (concussion or blast wave), mild ASI (contusion, stretch or partial cord transection), non-TBI brain injury and/or non-TSI spinal cord injury in a subject (animal or human). The method includes (a) obtaining a biological test sample from the subject, identifying metabolites in the subject's sample using metabolomics thereby obtaining a subject's metabolite matrix and generating a subject's profile using the patient's metabolite matrix; and (b) using multivariate statistical analysis and machine learning to compare the subject's profile with predetermined set of profiles of CNS injuries and a predetermined set of profiles of controls to determine if the subject has a CNS injury.
摘要:
The present invention relates to a method of producing expandable cultured brain cells. The brain cells are neurotrophic factor (NTF) positive. The expandable cultured brain cells are obtained by culturing a biopsy obtained from the cortical and/or subcortical brain region of a living subject. The biopsies can be obtained during neurosurgical procedures such as deep brain stimulation. The expandable cultured brain cells of the present invention are useful for the treatment of neurological diseases and other medical conditions.
摘要:
The present invention discloses methods of using bacterial profiles of breast samples for the diagnosis and prognosis of breast cancer. The present invention discloses also methods of using microorganisms in the prevention, risk reduction and treatment of breast cancer.
摘要:
The present invention describes a hands-free system for controlling the movement of a cursor on one or more display devices. A tracking device including a traceable marker and one or more accelerometers and gyroscopes are used to track position and acceleration of the marker relative to a target of interest. A processing means processes the motion signals from the tracking device to determine the location of the cursor on the operator's monitor, which may also be displayed on more monitors. The tracking device is worn by the operator, optimally on the operator's head. The operator's head movements determine movement of the cursor.
摘要:
The present invention provides new methods for treating, minimizing and/or preventing inflammatory injury involving IL-2 activity on epithelial cells expressing IL-2 receptors. Methods for reducing or preventing inflammatory injury in a tissue/organ comprise inhibiting IL-2 receptor activity in cells of the tissue/organ.
摘要:
A method for diagnosing prostate cancer in a subject, the method comprises measuring the methylation level of at least one CpG locus in a sample from the subject, wherein the at least one CpG locus is selected from the loci listed in Table 1 and/or is within about 1000, 900, 800, 700, 600, 500, 400, 300, 200, or 100 nucleotides of at least one of the loci listed in Table 1; and determining the level of similarity between the measured methylation level and a predefined level indicative of prostate cancer, wherein a high degree of similarity between the measured methylation level and the predefined level indicates the presence or increased likelihood of prostate cancer.
摘要:
Provided are methods and compositions for cartilage repair. The method involves performing a surgical procedure at the site of a cartilage defect and administering a composition comprising a receptor for hyaluronan mediated motility (RHAMM)-mimetic peptide, and a high molecular weight hyaluronan.